{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:23:26Z","timestamp":1793237006800,"version":"4.5.0"},"reference-count":18,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"abstract":"<jats:p>Cardiac troponins are indispensable biomarkers for the diagnosis of acute myocardial infarction, but false-positive elevations that contradict the clinical picture remain a significant challenge in laboratory medicine. Analytical interferences may arise from macrotroponins, heterophile or anti-troponin antibodies, and the limited cardiac specificity of high-sensitivity troponin T (hs-cTnT) in skeletal muscle disease. Recent studies show that hs-cTnT is elevated in up to two-thirds of patients with myopathies, while high-sensitivity troponin I (hs-cTnI) is largely unaffected, underscoring the diagnostic advantage of hs-cTnI in this setting. A pragmatic diagnostic approach should combine clinical plausibility with stepwise laboratory testing. First, preanalytical factors such as sample mislabeling, fibrin clots, or hemolysis must be excluded and the measurement repeated. If the results remain incongruent, an alternative assay \u2013 ideally hs-cTnI \u2013 should be performed. Further evaluation may include heterophile-blocking reagents, polyethylene glycol precipitation to screen for macro-analytes, and, where available, confirmatory techniques such as gel filtration chromatography or immunoglobulin depletion (protein A\/G). Although these strategies can help identify assay interference, there is no universally accepted gold standard. Awareness of false-positive elevations, careful interpretation of discordant troponin results, and effective collaboration between laboratories and clinicians are essential to prevent misdiagnosis and unnecessary interventions. Clear documentation of confirmed interferences further ensures safe patient management and provides guidance on which assays are reliable for future tests.<\/jats:p>","DOI":"10.33549\/physiolres.935683","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T15:36:28Z","timestamp":1764948988000},"page":"885","source":"Crossref","is-referenced-by-count":2,"title":["False-Positive Cardiac Troponin Elevations in Skeletal Muscle Disease: Clinical Relevance, Mechanisms, and Laboratory Approaches"],"prefix":"10.33549","author":[{"family":"Rajdl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"\u0160olcov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Racek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Such\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Vimmerov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Broz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Prokop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"19169","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"1.\tByrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023;44:3720-3826. https:\/\/doi.org\/10.1093\/eurheartj\/ehad191","DOI":"10.1093\/eurheartj\/ehad191"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2.\tThygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012;60:1581-1598. https:\/\/doi.org\/10.1016\/j.jacc.2012.08.001","DOI":"10.1016\/j.gheart.2012.08.001"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3.\tWarner JV, Marshall GA. High incidence of macrotroponin I with a high-sensitivity troponin I assay. Clin Chem Lab Med Vol 2016;54:1821-1829. https:\/\/doi.org\/10.1515\/cclm-2015-1276","DOI":"10.1515\/cclm-2015-1276"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4.\tBroz P, Racek J, Prokop P, Novak J, Rajdl D, Trefil L. Macrotroponins cause discrepancy in high-sensitivity examination. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2024;168:187-190. https:\/\/doi.org\/10.5507\/bp.2023.001","DOI":"10.5507\/bp.2023.001"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"5.\tKomrskov\u00e1 J, Franekov\u00e1 J, Jabor A. Makro-komplexy a mo\u017enosti jejich detekce. Klin Biochem Metab 2019;27:172-176. https:\/\/doi.org\/10.61568\/kbm.2019.025","DOI":"10.61568\/kbm.2019.025"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6.\tSalaun E, Drory S, Cot\u00e9 M-A, Tremblay V, B\u00e9dard E, Steinberg C, Par\u00e9 D, et al. Role of antitroponin antibodies and macrotroponin in the clinical interpretation of cardiac troponin. J Am Heart Assoc 2024;13:e035128. https:\/\/doi.org\/10.1161\/JAHA.123.035128","DOI":"10.1161\/JAHA.123.035128"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"7.\tSchmid J, Liesinger L, Birner-Gruenberger R, Stojakovic T, Scharnagl H, Dieplinger B, Asslaber M, et al. Elevated Cardiac Troponin T in Patients With Skeletal Myopathies. J Am Coll Cardiol 2018;71:1540-1549. https:\/\/doi.org\/10.1016\/j.jacc.2018.01.070","DOI":"10.1016\/j.jacc.2018.01.070"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"8.\tBarros E Silva PG, Machado LSG, Oliveira ACD, Mancuso FJN, Sato EI, Dias KT, Correia LAV, et al. High-sensitive cardiac troponin T in patients with idiopathic inflammatory myopathies. Eur Heart J 2024;45(Suppl 1):ehae666.3062. https:\/\/doi.org\/10.1093\/eurheartj\/ehae666.3062","DOI":"10.1093\/eurheartj\/ehae666.3062"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9.\tdu Fay de Lavallaz J, Prepoudis A, Wendebourg MJ, Kesenheimer E, Kyburz D, Daikeler T, Haaf P, et al. Skeletal muscle disorders: A noncardiac source of cardiac troponin T. Circulation 2022;145:1764-1779. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.058489","DOI":"10.1161\/CIRCULATIONAHA.121.058489"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10.\tJaffe AS, Vasile VC, Milone M, Saenger AK, Olson KN, Apple FS. Diseased Skeletal Muscle: A Noncardiac Source of Increased Circulating Concentrations of Cardiac Troponin T. J Am Coll Cardiol 2011;58:1819-1824. https:\/\/doi.org\/10.1016\/j.jacc.2011.08.026","DOI":"10.1016\/j.jacc.2011.08.026"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"11.\tChaulin AM. False-Positive Causes in Serum Cardiac Troponin Levels. J Clin Med Res 2022;14:80. https:\/\/doi.org\/10.14740\/jocmr4664","DOI":"10.14740\/jocmr4664"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12.\tFranekov\u00e1 J, Bl\u00e1ha M, B\u011blohoubek J, Kotrbat\u00e1 M, Se\u010dn\u00edk P Jr, Kub\u00ed\u010dek Z, Kettner J, Jabor A. A clinical and laboratory approach used to elucidate discordant results of high-sensitivity troponin T and troponin I. Clin Chim Acta 2015;446:128-131. https:\/\/doi.org\/10.1016\/j.cca.2015.03.046","DOI":"10.1016\/j.cca.2015.03.046"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"13.\tLam L, Ha L, Heron C, Chiu W, Kyle C. Identification of macrotroponin T: findings from a case report and non-reproducible troponin T results. Clin Chem Lab Med 2021;59:1972-1980. https:\/\/doi.org\/10.1515\/cclm-2021-0626","DOI":"10.1515\/cclm-2021-0626"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"14.\tKaplan E, Kissel CK, Bernasconi L, Lopez-Ayala P, Wittfooth S, Neyer P, Hure G, et al. False-positive cardiac troponin I values in healthy athletes post COVID-19 Infection: concerning insights from a prospective cohort study. Eur Heart J 2024;45(Suppl 1):ehae666.2753. https:\/\/doi.org\/10.1093\/eurheartj\/ehae666.2753","DOI":"10.1093\/eurheartj\/ehae666.2753"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"15.\tMakarious D, Zhou Y, Chung JZY, Ong ATL, Sivagangabalan G, Denniss AR, Thakkar JB, Chow CK. Macrotroponin: A case series and review of the literature. Heart Lung Circ 2025;34:e134-e139. https:\/\/doi.org\/10.1016\/j.hlc.2025.03.006","DOI":"10.1016\/j.hlc.2025.03.006"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16.\tFahie-Wilson M, Halsall D. Polyethylene glycol precipitation: proceed with care. Ann Clin Biochem 2008;45:233-235. https:\/\/doi.org\/10.1258\/acb.2008.007262","DOI":"10.1258\/acb.2008.007262"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"17.\tDavidson DF, Watson DJM. Macroenzyme detection by polyethylene glycol precipitation. Ann Clin Biochem 2003;40:514-520. https:\/\/doi.org\/10.1258\/000456303322326425","DOI":"10.1258\/000456303322326425"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"18.\tHammarsten O, Warner JV, Lam L, Kavsak P, Lindahl B, Aakre KM, Collinson P, et al. Antibody-mediated interferences affecting cardiac troponin assays: recommendations from the IFCC Committee on Clinical Applications of Cardiac Biomarkers. Clin Chem Lab Med 2023;61:1411-1419. https:\/\/doi.org\/10.1515\/cclm-2023-0028","DOI":"10.1515\/cclm-2023-0028"}],"container-title":["Physiological Research"],"original-title":[],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T15:36:37Z","timestamp":1764948997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2025\/74_885.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":18,"URL":"https:\/\/doi.org\/10.33549\/physiolres.935683","relation":{},"ISSN":["0862-8408","1802-9973"],"issn-type":[{"value":"0862-8408","type":"print"},{"value":"1802-9973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]}}}